Search - tctmd.com

Displaying 281 - 300 of 807

Sort: Relevancy | Date

News Industry News

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

May 12, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

Sarcopenia, Pulmonary Abnormalities Useful Risk Markers in Aortic Valve Replacement

April 30, 2015

News Daily News

分期 PCI 和 TAVR 之间的时间对短期结局有极轻微影响

Yael L. Maxwell

April 29, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

News Daily News

El Tiempo Transcurrido entre PCI por Etapas y TAVR Influye Mínimamente en los Resultados a Corto Plazo

Yael L. Maxwell

April 29, 2015

Presentation ECHO 2015

Echocardiography for Aortic Stenosis

Presenter: Fletcher A. Miller

April 28, 2015

Presentation ECHO 2015

Aortic Stenosis Quantitation: Old and New Methods of Assessment

Presenter: Philippe Pibarot

April 27, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Todd Neale

April 10, 2015

News Industry News

Direct Flow Medical, Inc Announces FDA Approval to Broaden SALUS U.S. Pivotal Trial

April 09, 2015

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

News Daily News

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Yael L. Maxwell

April 03, 2015

News Industry News

Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

March 31, 2015

News Industry News

Medtronic Announces Japanese Regulatory Approval of CoreValve® System

March 30, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

Presentation

5-Year Outcomes of TAVR vs Standard Treatment for Patients With Inoperable Aortic Stenosis

Presenter: Samir R. Kapadia

March 25, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Industry News

Protégé GPS Self-Expanding Peripheral Stent System Receives FDA Approval for Use in Treating Iliac Artery Stenosis

March 18, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Industry News

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

March 15, 2015

Advertisement

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

Sarcopenia, Pulmonary Abnormalities Useful Risk Markers in Aortic Valve Replacement

分期 PCI 和 TAVR 之间的时间对短期结局有极轻微影响

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

El Tiempo Transcurrido entre PCI por Etapas y TAVR Influye Mínimamente en los Resultados a Corto Plazo

Echocardiography for Aortic Stenosis

Aortic Stenosis Quantitation: Old and New Methods of Assessment

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Direct Flow Medical, Inc Announces FDA Approval to Broaden SALUS U.S. Pivotal Trial

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

Medtronic Announces Japanese Regulatory Approval of CoreValve® System

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

5-Year Outcomes of TAVR vs Standard Treatment for Patients With Inoperable Aortic Stenosis

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Protégé GPS Self-Expanding Peripheral Stent System Receives FDA Approval for Use in Treating Iliac Artery Stenosis

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content